Insider Trading activities of Aegerion Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aegerion Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aegerion Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Aegerion Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is AEGR. The reporting company's CIK number is 1338042.
The total value of stock buying since 2005 is $49,568,574.
The total value of stock sales since 2005 is $137,504,077.
The total value of stock option exercises since 2005 is $2,086,087.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aegerion Pharmaceuticals, Inc. (AEGR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-09 351,000 $589,598 0 $0 1,642 $0
2016-07 0 $0 0 $0 2,222 $0
2016-04 0 $0 0 $0 867 $0
2016-01 0 $0 0 $0 2,223 $0
2015-11 40,100 $440,097 0 $0 0 $0
2014-08 1,150 $35,236 0 $0 0 $0
2014-07 10,000 $339,050 0 $0 0 $0
2014-06 10,000 $301,200 0 $0 0 $0
2014-05 54,000 $1,817,592 0 $0 6,400 $9,856
2014-04 0 $0 2,250 $97,965 2,250 $29,272
2014-03 0 $0 4,250 $206,649 9,750 $104,012
2014-02 0 $0 11,750 $752,897 11,750 $187,592
2014-01 0 $0 5,250 $348,739 5,250 $68,302
2013-12 0 $0 7,250 $504,593 11,630 $101,067
2013-11 0 $0 20,250 $1,622,622 62,100 $417,661
2013-10 0 $0 68,002 $6,222,369 68,002 $430,885
2013-09 0 $0 752,000 $67,080,580 2,000 $26,020
2013-08 0 $0 99,500 $8,840,187 82,000 $451,220
2013-07 0 $0 2,000 $157,220 2,000 $26,020
2013-06 0 $0 6,000 $395,130 6,000 $78,060
2013-05 0 $0 6,000 $283,932 6,000 $78,060
2013-04 0 $0 6,000 $245,268 6,000 $78,060
2013-02 50,000 $1,389,400 0 $0 0 $0
2013-01 575,500 $15,546,230 0 $0 0 $0
2012-12 20,000 $425,400 0 $0 0 $0
2012-11 180,000 $3,868,300 0 $0 0 $0
2012-10 0 $0 200,733 $3,679,056 0 $0
2012-03 3,500 $48,805 397,794 $6,312,192 0 $0
2012-01 0 $0 348,344 $5,968,601 0 $0
2011-12 0 $0 102,742 $1,736,930 0 $0
2011-09 6,754 $99,655 0 $0 0 $0
2011-08 29,465 $361,531 0 $0 0 $0
2011-07 0 $0 20,390 $297,875 0 $0
2011-06 69,848 $1,099,759 2,241,856 $32,751,272 0 $0
2011-04 5,957 $99,660 0 $0 0 $0
2011-03 10,000 $152,601 0 $0 0 $0
2010-12 200 $2,465 0 $0 0 $0
2010-10 2,416,000 $22,951,995 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aegerion Pharmaceuticals, Inc. insiders (AEGR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-09-17 Harshbarger Benjamin (General Counsel) Option Ex 1,642 .00 0
2016-09-13 Broadfin Capital, Llc Buy 75,000 1.75 131,250
2016-09-12 Kotler Kevin Buy 176,000 1.70 298,848
2016-09-09 Kotler Kevin Buy 100,000 1.59 159,500
2016-07-27 Smith Sandford D (Director) Option Ex 2,222 .00 0
2016-04-01 Harshbarger Benjamin (General Counsel) Option Ex 867 .00 0
2016-01-27 Smith Sandford D (Director) Option Ex 2,223 .00 0
2015-11-11 Kotler Kevin Buy 40,100 10.97 440,097
2014-08-19 Fitzpatrick Mark J. (Chief Financial Officer) Buy 1,150 30.64 35,236
2014-07-31 Beer Marc D (Chief Executive Officer) Buy 10,000 33.91 339,050
2014-06-03 Beer Marc D (Chief Executive Officer) Buy 10,000 30.12 301,200
2014-05-27 Beer Marc D (Chief Executive Officer) Buy 10,000 31.59 315,900
2014-05-21 Beer Marc D (Chief Executive Officer) Option Ex 6,400 1.54 9,856
2014-05-20 Beer Marc D (Chief Executive Officer) Buy 10,000 30.53 305,300
2014-05-08 Beer Marc D (Chief Executive Officer) Buy 30,000 35.31 1,059,300
2014-05-08 Vanlent Anne (Director) Buy 4,000 34.27 137,092
2014-04-30 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Sale 2,250 43.54 97,965
2014-04-30 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Option Ex 2,250 13.01 29,272
2014-03-31 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Sale 2,250 46.52 104,663
2014-03-31 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Option Ex 2,250 13.01 29,272
2014-03-26 Beer Marc D (Chief Executive Officer) Option Ex 3,000 1.54 4,620
2014-03-14 Sumeray Mark (Chief Medical Officer) Sale 2,000 50.99 101,986
2014-03-14 Sumeray Mark (Chief Medical Officer) Option Ex 2,000 13.01 26,020
2014-03-04 Fitzpatrick Mark J. (Chief Financial Officer) Option Ex 2,500 17.64 44,100
2014-02-14 Sumeray Mark (Chief Medical Officer) Sale 2,000 63.83 127,660
2014-02-14 Sumeray Mark (Chief Medical Officer) Option Ex 2,000 13.01 26,020
2014-02-11 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Sale 2,250 67.00 150,750
2014-02-11 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Option Ex 2,250 13.01 29,272
2014-02-10 Fitzpatrick Mark J. (Chief Financial Officer) Sale 7,500 63.27 474,487
2014-02-10 Fitzpatrick Mark J. (Chief Financial Officer) Option Ex 7,500 17.64 132,300
2014-01-16 Sumeray Mark (Chief Medical Officer) Sale 2,000 59.05 118,098
2014-01-16 Sumeray Mark (Chief Medical Officer) Option Ex 2,000 13.01 26,020
2014-01-02 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Sale 2,250 71.03 159,826
2014-01-02 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Option Ex 2,250 13.01 29,272
2014-01-02 Sumeray Mark (Chief Medical Officer) Sale 1,000 70.81 70,815
2014-01-02 Sumeray Mark (Chief Medical Officer) Option Ex 1,000 13.01 13,010
2013-12-16 Sumeray Mark (Chief Medical Officer) Sale 2,000 66.80 133,608
2013-12-16 Sumeray Mark (Chief Medical Officer) Option Ex 2,000 13.01 26,020
2013-12-04 Beer Marc D (Chief Executive Officer) Option Ex 4,380 1.54 6,745
2013-12-02 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Sale 2,250 70.60 158,847
2013-12-02 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Option Ex 2,250 13.01 29,272
2013-12-02 Sumeray Mark (Chief Medical Officer) Sale 3,000 70.71 212,138
2013-12-02 Sumeray Mark (Chief Medical Officer) Option Ex 3,000 13.01 39,030
2013-11-15 Sumeray Mark (Chief Medical Officer) Sale 2,000 76.15 152,302
2013-11-15 Sumeray Mark (Chief Medical Officer) Option Ex 2,000 13.01 26,020
2013-11-11 Fitzpatrick Mark J. (Chief Financial Officer) Sale 7,500 76.89 576,675
2013-11-11 Fitzpatrick Mark J. (Chief Financial Officer) Option Ex 10,350 17.64 182,574
2013-11-05 Beer Marc D (Chief Executive Officer) Option Ex 39,000 1.54 60,060
2013-11-01 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Sale 2,250 83.17 187,121
2013-11-01 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Option Ex 2,250 13.01 29,272
2013-11-01 Sumeray Mark (Chief Medical Officer) Sale 3,500 83.56 292,474
2013-11-01 Sumeray Mark (Chief Medical Officer) Option Ex 3,500 13.01 45,535
2013-11-01 Carter Martha J. (Chief Regulatory Officer & SVP) Sale 5,000 82.81 414,050
2013-11-01 Carter Martha J. (Chief Regulatory Officer & SVP) Option Ex 5,000 14.84 74,200
2013-10-30 Beer Marc D (Chief Executive Officer) Sale 40,000 90.34 3,613,600
2013-10-30 Beer Marc D (Chief Executive Officer) Option Ex 40,000 1.54 61,600
2013-10-29 Smith Sandford D (Director) Sale 2,502 95.00 237,690
2013-10-29 Smith Sandford D (Director) Option Ex 2,502 15.00 37,530
2013-10-15 Sumeray Mark (Chief Medical Officer) Sale 2,000 80.33 160,658
2013-10-15 Sumeray Mark (Chief Medical Officer) Option Ex 2,000 13.01 26,020
2013-10-07 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Sale 20,000 94.16 1,883,280
2013-10-07 Fraser Craig (Pres., US/Int. Comm. & Manuf.) Option Ex 20,000 13.01 260,200
2013-10-07 Sumeray Mark (Chief Medical Officer) Sale 3,500 93.47 327,141
2013-10-07 Sumeray Mark (Chief Medical Officer) Option Ex 3,500 13.01 45,535
2013-09-16 Sumeray Mark (Chief Medical Officer) Sale 2,000 90.29 180,580
2013-09-16 Sumeray Mark (Chief Medical Officer) Option Ex 2,000 13.01 26,020
2013-09-05 Perceptive Life Sciences Master Fund Ltd Sale 750,000 89.20 66,900,000
2013-08-26 Fitzpatrick Mark J. (Chief Financial Officer) Option Ex 2,500 17.64 44,100
2013-08-21 Scheer David (Director) Sale 20,000 84.82 1,696,399
2013-08-16 Sumeray Mark (Chief Medical Officer) Sale 2,000 88.97 177,938
2013-08-16 Sumeray Mark (Chief Medical Officer) Option Ex 2,000 13.01 26,020
2013-08-15 Beer Marc D (Chief Executive Officer) Sale 60,000 89.01 5,340,420
2013-08-15 Beer Marc D (Chief Executive Officer) Option Ex 60,000 1.54 92,400
2013-08-14 Fitzpatrick Mark J. (Chief Financial Officer) Sale 7,500 93.63 702,225
2013-08-14 Fitzpatrick Mark J. (Chief Financial Officer) Option Ex 7,500 17.64 132,300
2013-08-12 Smith Sandford D (Director) Sale 1,537 92.25 141,791
2013-08-09 Smith Sandford D (Director) Sale 8,463 92.33 781,414
2013-08-09 Smith Sandford D (Director) Option Ex 10,000 15.64 156,400
2013-07-15 Sumeray Mark (Chief Medical Officer) Sale 2,000 78.61 157,220
2013-07-15 Sumeray Mark (Chief Medical Officer) Option Ex 2,000 13.01 26,020
2013-06-17 Sumeray Mark (Chief Medical Officer) Sale 6,000 65.86 395,130
2013-06-17 Sumeray Mark (Chief Medical Officer) Option Ex 6,000 13.01 78,060
2013-05-15 Sumeray Mark (Chief Medical Officer) Sale 6,000 47.32 283,932
2013-05-15 Sumeray Mark (Chief Medical Officer) Option Ex 6,000 13.01 78,060
2013-04-22 Sumeray Mark (Chief Medical Officer) Sale 6,000 40.88 245,268
2013-04-22 Sumeray Mark (Chief Medical Officer) Option Ex 6,000 13.01 78,060
2013-02-01 Perceptive Life Sciences Master Fund Ltd Buy 50,000 27.79 1,389,400
2013-01-23 Carter Martha J. (Chief Regulatory Officer & SVP) Buy 500 27.81 13,905
2013-01-18 Perceptive Life Sciences Master Fund Ltd Buy 50,000 27.62 1,381,000
2013-01-17 Perceptive Life Sciences Master Fund Ltd Buy 50,000 26.73 1,336,300
2013-01-11 Perceptive Life Sciences Master Fund Ltd Buy 475,000 26.98 12,815,025
2012-12-04 Perceptive Life Sciences Master Fund Ltd Buy 20,000 21.27 425,400
2012-11-29 Edelman Joseph Buy 30,000 22.71 681,300
2012-11-28 Edelman Joseph Buy 70,000 21.76 1,523,200
2012-11-21 Edelman Joseph Buy 20,000 20.75 415,000
2012-11-20 Edelman Joseph Buy 20,000 21.01 420,200
2012-11-15 Edelman Joseph Buy 10,000 19.50 195,000
2012-11-07 Edelman Joseph Buy 30,000 21.12 633,600
2012-10-16 Kiley Alison (10% Owner) Sale 140,000 18.67 2,613,800
2012-10-15 Kiley Alison (10% Owner) Sale 60,733 17.54 1,065,256
2012-03-30 Carter Martha J. (Chief Regulatory Officer) Buy 1,000 14.03 14,030
2012-03-29 Beer Marc D (Chief Executive Officer) Buy 1,000 13.73 13,735
2012-03-23 Fitzpatrick Mark J. (Chief Financial Officer) Buy 500 14.15 7,076
2012-03-22 Beer Marc D (Chief Executive Officer) Buy 1,000 13.96 13,964
2012-03-09 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Sale 58,820 15.87 933,355
2012-03-09 Advent Partners Hls Iii Limited Partnership (Other) Sale 1,103 15.87 17,502
2012-03-09 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Sale 40,077 15.87 635,941
2012-03-09 Ahls Iii Gp Limited Partnership (Other) Sale 98,897 15.87 1,569,297
2012-03-09 Advent International Llc (Other) Sale 98,897 15.87 1,569,297
2012-03-09 Advent International Corp/ma (Other) Sale 100,000 15.87 1,586,800
2012-01-31 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Sale 13,117 17.10 224,326
2012-01-31 Advent Partners Hls Iii Limited Partnership (Other) Sale 246 17.10 4,207
2012-01-31 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Sale 8,937 17.10 152,840
2012-01-31 Ahls Iii Gp Limited Partnership (Other) Sale 22,054 17.10 377,167
2012-01-31 Advent International Llc (Other) Sale 22,054 17.10 377,167
2012-01-31 Advent International Corp/ma (Other) Sale 22,300 17.10 381,374
2012-01-30 Yucca Partners L.p. Jersey Branch (10% Owner) Sale 50,000 17.08 853,999
2012-01-30 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Sale 1,588 17.07 27,099
2012-01-30 Advent Partners Hls Iii Limited Partnership (Other) Sale 30 17.07 511
2012-01-30 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Sale 1,082 17.07 18,464
2012-01-30 Ahls Iii Gp Limited Partnership (Other) Sale 2,670 17.07 45,563
2012-01-30 Advent International Llc (Other) Sale 2,670 17.07 45,563
2012-01-30 Advent International Corp/ma (Other) Sale 2,700 17.07 46,075
2012-01-27 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Sale 29,409 17.17 504,834
2012-01-27 Advent Partners Hls Iii Limited Partnership (Other) Sale 552 17.17 9,475
2012-01-27 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Sale 20,039 17.17 343,989
2012-01-27 Ahls Iii Gp Limited Partnership (Other) Sale 49,448 17.17 848,824
2012-01-27 Advent International Llc (Other) Sale 49,448 17.17 848,824
2012-01-27 Advent International Corp/ma (Other) Sale 50,000 17.17 858,300
2011-12-09 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Sale 10,448 16.89 176,477
2011-12-09 Advent Partners Hls Iii Limited Partnership (Other) Sale 196 16.89 3,310
2011-12-09 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Sale 7,119 16.89 120,247
2011-12-09 Ahls Iii Gp Limited Partnership (Other) Sale 17,567 16.89 296,724
2011-12-09 Advent International Llc (Other) Sale 17,567 16.89 296,724
2011-12-09 Advent International Corp/ma (Other) Sale 17,763 16.89 300,034
2011-12-08 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Sale 1,470 16.89 24,835
2011-12-08 Advent Partners Hls Iii Limited Partnership (Other) Sale 28 16.89 473
2011-12-08 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Sale 1,002 16.89 16,928
2011-12-08 Ahls Iii Gp Limited Partnership (Other) Sale 2,472 16.89 41,764
2011-12-08 Advent International Llc (Other) Sale 2,472 16.89 41,764
2011-12-08 Advent International Corp/ma (Other) Sale 2,500 16.89 42,237
2011-12-06 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Sale 3,274 16.96 55,520
2011-12-06 Advent Partners Hls Iii Limited Partnership (Other) Sale 61 16.96 1,034
2011-12-06 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Sale 2,230 16.96 37,816
2011-12-06 Ahls Iii Gp Limited Partnership (Other) Sale 5,504 16.96 93,336
2011-12-06 Advent International Llc (Other) Sale 5,504 16.96 93,336
2011-12-06 Advent International Corp/ma (Other) Sale 5,565 16.96 94,371
2011-09-01 Beer Marc D (Chief Executive Officer) Buy 6,754 14.76 99,655
2011-08-09 Kiley Alison (Director) Buy 5,500 12.45 68,497
2011-08-09 Beer Marc D (Chief Executive Officer) Buy 10,065 11.94 120,125
2011-08-09 Alta Embarcadero Biopharma Partners Iii Llc (10% Owner) Buy 5,500 12.45 68,497
2011-08-08 Kiley Alison (Director) Buy 4,200 12.43 52,206
2011-08-08 Alta Embarcadero Biopharma Partners Iii Llc (10% Owner) Buy 4,200 12.43 52,206
2011-07-29 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Sale 3,015 14.61 44,046
2011-07-29 Advent Partners Hls Iii Limited Partnership (Other) Sale 57 14.61 832
2011-07-29 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Sale 2,054 14.61 30,006
2011-07-29 Ahls Iii Gp Limited Partnership (Other) Sale 5,069 14.61 74,053
2011-07-29 Advent International Llc (Other) Sale 5,069 14.61 74,053
2011-07-29 Advent International Corp/ma (Other) Sale 5,126 14.61 74,885
2011-06-29 Ollier Michele (Director) Sale 877,723 14.61 12,822,655
2011-06-29 Yucca Partners L.p. Jersey Branch (10% Owner) Sale 877,723 14.61 12,822,655
2011-06-29 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Sale 71,923 14.61 1,050,723
2011-06-29 Advent Partners Hls Iii Limited Partnership (Other) Sale 1,349 14.61 19,707
2011-06-29 Beer Marc D (Chief Executive Officer) Buy 64,516 15.50 999,998
2011-06-29 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Sale 49,005 14.61 715,914
2011-06-29 Ahls Iii Gp Limited Partnership (Other) Sale 120,928 14.61 1,766,637
2011-06-29 Advent International Llc (Other) Sale 120,928 14.61 1,766,637
2011-06-29 Advent International Corp/ma (Other) Sale 122,277 14.61 1,786,344
2011-06-01 Beer Marc D (Chief Executive Officer) Buy 5,332 18.71 99,761
2011-04-04 Beer Marc D (Chief Executive Officer) Buy 5,957 16.73 99,660
2011-03-11 Scheer David (Director) Buy 6,006 15.36 92,252
2011-03-10 Scheer David (Director) Buy 3,994 15.11 60,349
2010-12-15 Beer Marc D (Chief Executive Officer) Buy 200 12.33 2,465
2010-10-27 Ollier Michele (Director) Buy 315,789 9.50 2,999,995
2010-10-27 Yucca Partners L.p. Jersey Branch (10% Owner) Buy 315,789 9.50 2,999,995
2010-10-27 Advent Healthcare & Life Sciences Iii-a Limited Partnership (Other) Buy 154,790 9.50 1,470,505
2010-10-27 Advent Partners Hls Iii Limited Partnership (Other) Buy 2,895 9.50 27,502
2010-10-27 Kiley Alison (Director) Buy 315,789 9.50 2,999,995
2010-10-27 Beer Marc D (Chief Executive Officer) Buy 105,263 9.50 999,998
2010-10-27 Advent Healthcare & Life Sciences Iii Limited Partnership (Other) Buy 105,473 9.50 1,001,993
2010-10-27 Ahls Iii Gp Limited Partnership (Other) Buy 260,263 9.50 2,472,498
2010-10-27 Advent International Llc (Other) Buy 260,263 9.50 2,472,498
2010-10-27 Hurwitz Edward (10% Owner) Buy 315,789 9.50 2,999,995
2010-10-27 Fisherman Jason S (Director) Buy 739 9.50 7,020
2010-10-27 Advent International Corp/ma (Other) Buy 263,158 9.50 2,500,001

Insider trading activities including stock purchases, stock sales, and option exercises of AEGR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aegerion Pharmaceuticals, Inc. (symbol AEGR, CIK number 1338042) see the Securities and Exchange Commission (SEC) website.